Compare REXR & ATR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | REXR | ATR |
|---|---|---|
| Founded | 2013 | 1992 |
| Country | United States | United States |
| Employees | 256 | N/A |
| Industry | Real Estate Investment Trusts | Plastic Products |
| Sector | Real Estate | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.4B | 8.1B |
| IPO Year | N/A | 1995 |
| Metric | REXR | ATR |
|---|---|---|
| Price | $36.04 | $125.43 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 4 |
| Target Price | $41.00 | ★ $170.25 |
| AVG Volume (30 Days) | ★ 2.3M | 369.5K |
| Earning Date | 04-23-2026 | 04-30-2026 |
| Dividend Yield | ★ 4.91% | 1.55% |
| EPS Growth | N/A | ★ 6.51 |
| EPS | N/A | ★ 5.89 |
| Revenue | N/A | ★ $3,777,181,000.00 |
| Revenue This Year | $0.09 | $5.18 |
| Revenue Next Year | $2.99 | $4.98 |
| P/E Ratio | $43.28 | ★ $20.97 |
| Revenue Growth | N/A | ★ 5.42 |
| 52 Week Low | $32.14 | $103.23 |
| 52 Week High | $44.38 | $164.28 |
| Indicator | REXR | ATR |
|---|---|---|
| Relative Strength Index (RSI) | 55.41 | 43.70 |
| Support Level | $35.66 | $118.30 |
| Resistance Level | $37.77 | $133.07 |
| Average True Range (ATR) | 0.93 | 3.31 |
| MACD | 0.21 | -0.40 |
| Stochastic Oscillator | 61.26 | 27.49 |
Rexford Industrial Realty Inc is a real estate investment trust focused on owning, operating and acquiring industrial properties in Southern California infill markets. Its goal is to generate attractive risk-adjusted returns for the stockholders by providing superior access to industrial property investments and mortgage debt investments secured by industrial property in high-barrier Southern California infill markets. The company generates revenue from rental income derived from properties in its portfolio.
Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. Its sales are primarily from Europe (49% of sales) and the United States (28%), with China contributing 5% and other countries contributing 17%. It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.